TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
1.690
+0.040 (2.42%)
Jun 23, 2025, 4:00 PM - Market closed
TELA Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
| Revenue | 71.22 | 69.3 | 58.45 | 41.42 | 29.46 | 18.21 | Upgrade
|
| Revenue Growth (YoY) | 12.78% | 18.56% | 41.13% | 40.58% | 61.77% | 17.91% | Upgrade
|
| Cost of Revenue | 23.17 | 22.43 | 17.96 | 13.57 | 10.35 | 6.68 | Upgrade
|
| Gross Profit | 48.04 | 46.87 | 40.49 | 27.85 | 19.12 | 11.54 | Upgrade
|
| Selling, General & Admin | 78.47 | 79.37 | 74.57 | 57.11 | 41.52 | 32.25 | Upgrade
|
| Research & Development | 8.96 | 8.81 | 9.62 | 8.94 | 6.74 | 4.26 | Upgrade
|
| Operating Expenses | 87.81 | 88.56 | 84.57 | 66.86 | 48.57 | 36.81 | Upgrade
|
| Operating Income | -39.76 | -41.7 | -44.08 | -39.01 | -29.45 | -25.28 | Upgrade
|
| Interest Expense | -5.18 | -5.29 | -5.22 | -4.05 | -3.6 | -3.56 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.4 | 1.42 | 2.63 | -0.01 | -0.23 | 0.05 | Upgrade
|
| EBT Excluding Unusual Items | -43.54 | -45.57 | -46.66 | -43.07 | -33.28 | -28.79 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 7.58 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | -1.23 | - | - | Upgrade
|
| Pretax Income | -43.54 | -37.99 | -46.66 | -44.3 | -33.28 | -28.79 | Upgrade
|
| Income Tax Expense | -0.09 | -0.14 | - | - | - | - | Upgrade
|
| Net Income | -43.44 | -37.84 | -46.66 | -44.3 | -33.28 | -28.79 | Upgrade
|
| Net Income to Common | -43.44 | -37.84 | -46.66 | -44.3 | -33.28 | -28.79 | Upgrade
|
| Shares Outstanding (Basic) | 34 | 29 | 23 | 16 | 14 | 13 | Upgrade
|
| Shares Outstanding (Diluted) | 34 | 29 | 23 | 16 | 14 | 13 | Upgrade
|
| Shares Change (YoY) | 39.15% | 24.74% | 40.58% | 12.40% | 11.90% | 632.24% | Upgrade
|
| EPS (Basic) | -1.29 | -1.33 | -2.04 | -2.72 | -2.30 | -2.23 | Upgrade
|
| EPS (Diluted) | -1.29 | -1.33 | -2.04 | -2.72 | -2.30 | -2.23 | Upgrade
|
| Free Cash Flow | -37.65 | -42.58 | -41.47 | -41.62 | -31.06 | -24.62 | Upgrade
|
| Free Cash Flow Per Share | -1.12 | -1.49 | -1.81 | -2.56 | -2.15 | -1.90 | Upgrade
|
| Gross Margin | 67.46% | 67.63% | 69.27% | 67.24% | 64.89% | 63.35% | Upgrade
|
| Operating Margin | -55.83% | -60.17% | -75.40% | -94.18% | -99.96% | -138.78% | Upgrade
|
| Profit Margin | -61.00% | -54.61% | -79.83% | -106.95% | -112.94% | -158.10% | Upgrade
|
| Free Cash Flow Margin | -52.87% | -61.45% | -70.94% | -100.49% | -105.42% | -135.19% | Upgrade
|
| EBITDA | -38.72 | -40.68 | -43.27 | -37.82 | -28.92 | -24.75 | Upgrade
|
| EBITDA Margin | -54.36% | -58.71% | -74.02% | -91.31% | -98.14% | -135.89% | Upgrade
|
| D&A For EBITDA | 1.05 | 1.01 | 0.81 | 1.19 | 0.54 | 0.53 | Upgrade
|
| EBIT | -39.76 | -41.7 | -44.08 | -39.01 | -29.45 | -25.28 | Upgrade
|
| EBIT Margin | -55.83% | -60.17% | -75.40% | -94.18% | -99.96% | -138.77% | Upgrade
|
Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.